org placeholder image

Sang Lee

VP of Biology at Prelude Therapeutics

  • LinkedIn

Email Email: s****@incyte.com

phone noPhone Number: (***)-***-****

map
PRELUDE THERAPEUTICS

PRELUDE THERAPEUTICS

  • description Description
    Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways. The Companys diverse pipeline is comprised o...

    Read More

  • Employees count Employees 51-200
  • Revenue Revenue 25 Million to 50 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Prelude Therapeutics Org Chart and Mapping

Kris Vaddi

Chief Executive Officer and Founder

VP-Level
VP-Level
Employees

Saishuai Wen

Senior Research Scientist

Ganfeng 曹敢峰

Vice President and Head of Process Chemistry, Cmc

Sarah Rowe

Associate Director, Clinical Operations

Karl Blom

Executive Director, Discovery Chemistry Analytical

Ann Lacivita

Executive Assistant to President and CMO

Soham Maity

Sr. Research Scientist

Joy Cote

Senior Research Scientist Biochemistry

Frequently Asked Questions Regarding Sang Lee

Answer: Sang Lee works for Prelude Therapeutics as VP of Biology

Answer: Sang Lee’s role in Prelude Therapeutics is VP of Biology

Answer: Sang Lee's email address is s***@gmail.com

Answer: Sang Lee's business email address is s****@incyte.com

Answer: Sang Lee’s direct phone number is (***)-***-****

Answer: Sang Lee works in the industry of: Biotechnology

Answer: Sang Lee works Prelude Therapeutics located at 200 Powder ML Rd, Wilmington, Delaware, 19803, United States

Answer: Prelude Therapeutics's VP of Biology is Sang Lee

Answer: Sang Lee contact details:

  • Phone number  :  (***)-***-****
  • Email  :  s****@incyte.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access